Vanguard Personalized Indexing Management, LLC

Position in DNLI — Denali Therapeutics Inc.

CIK 1767306 OAKLAND, CA

Position in DNLI

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$307,431

+$84,289 QoQ

Shares Held

11,953

+2.8% QoQ

Ownership

0.007%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#179

of 290 holders

Holding Since

Jun 2021

9 quarters on record

Voting authority Sole 87% Shared 0% None 13%

Healthcare · as of Jun 30, 2026

Vanguard Personalized Indexing Management, LLC holds $97,369,187 across 138 Biotechnology names. DNLI ranks #59 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	43,151	$21,434,396
2	REGN	Regeneron Pharmaceuticals, Inc.	11,712	$7,302,900
3	INCY	Incyte Corp	34,556	$3,917,268
4	ARGX	Argenx SE	4,103	$3,806,640
5	ALNY	Alnylam Pharmaceuticals, Inc.	11,436	$3,442,579
6	RVMD	Revolution Medicines, Inc.	17,697	$3,314,294
7	MRNA	Moderna, Inc.	43,679	$3,058,840
8	HALO	Halozyme Therapeutics, Inc.	30,414	$2,380,503

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$307,431	11,953	+2.8%	Shares	Sole	2026-08-11
2026-03-31	$223,142	11,622	-1.0%	Shares	Sole	2026-05-14
2025-12-31	$193,761	11,736	-6.3%	Shares	Sole	2026-02-13
2025-09-30	$181,877	12,526	-18.3%	Shares	Sole	2025-10-31
2025-06-30	$214,452	15,329	+34.7%	Shares	Sole	2025-07-25
2024-12-31	$231,863	11,377	-11.7%	Shares	Sole	2025-02-10
2024-09-30	$375,485	12,890	+19.5%	Shares	Sole	2024-11-12
2024-06-30	$250,543	10,790	+79.5%	Shares	Sole	2024-08-12
2021-06-30	$471,581	6,012	—	Shares	Sole	2021-08-11
No filing history on record for this holder in this stock.